What is Power?
Power operates at the intersection of health-tech and patient advocacy, providing a sophisticated platform designed to simplify the discovery and evaluation of clinical trials. The company addresses a critical market failure where approximately 86% of clinical trials face delays due to recruitment challenges. By replacing convoluted, jargon-heavy processes with a user-friendly interface, Power empowers patients to access cutting-edge research that may otherwise remain inaccessible. This market position is bolstered by a commitment to transparency and accessibility, effectively democratizing participation in medical innovation and reducing the time-to-market for breakthrough therapeutics.
How much funding has Power raised?
Power has raised a total of $19M across 2 funding rounds:
Angel/Seed
$7M
Series A
$12M
Angel/Seed (2022): $7M with participation from Footwork, AirAngels, South Park Commons, Artis Ventures Management Iii, and Charles River Ventures
Series A (2024): $12M led by Contrary Capital and Kin Ventures
Key Investors in Power
Artis Ventures Management Iii
Artis Ventures is a dedicated venture capital fund focused on Tech Bio+Health, investing in innovative data-driven life sciences companies that aim to enhance human health and wellness.
Charles River Ventures
CRV is a venture capital firm that invests in early-stage tech startups, providing long-term partnership and support from founding through to IPO.
Contrary Capital
Contrary is a venture fund that supports the world's top early-career talent, identifying and investing in companies started by emerging engineers and product minds.
What's next for Power?
With this latest capital injection, Power is poised to scale its operations and deepen its integration within the clinical research ecosystem. The strategic focus will likely shift toward expanding its network of research partners and enhancing its proprietary matching algorithms to further reduce recruitment friction. As the company matures, it is expected to play an increasingly central role in the digital transformation of clinical trials, potentially setting new industry standards for patient engagement and data-driven recruitment. The backing from high-profile venture firms suggests a long-term commitment to building a sustainable, high-impact enterprise that fundamentally alters how medical research is conducted on a global scale.
See full Power company page
